
A meta-analysis of 7 real-world studies found maternal RSVpreF 78% effective against RSV LRTI hospitalization in infants up to 6 months.
Recurrent rhinorrhea can present a diagnostic challenge. The authors offer tips for sorting through the differential and recommend a minimalist, individualized approach to management.






